Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
0.34
0.01 (4.17%)
At close: May 30, 2025, 3:59 PM
0.34
0.00%
After-hours: May 30, 2025, 07:49 PM EDT
Applied DNA Sciences Revenue Breakdown
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2020 | Sep 30, 2019 |
|---|---|---|---|---|
| Asset Marking Revenue | 9.44K | 311.81K | 400.49K | 587.01K |
| Asset Marking Revenue Growth | -96.97% | -22.14% | -31.77% | n/a |
| Clinical Laboratory Testing Services (Over-Time) Revenue | 1.29M | 3.54M | 38.58K | 1.44M |
| Clinical Laboratory Testing Services (Over-Time) Revenue Growth | -63.70% | +9077.63% | -97.32% | n/a |
| Clinical Laboratory Testing Services (Point-in-Time) Revenue | 32.61K | 7.61M | n/a | n/a |
| Clinical Laboratory Testing Services (Point-in-Time) Revenue Growth | -99.57% | n/a | n/a | n/a |
| Large Scale DNA Production Revenue | 584.12K | 653.01K | n/a | n/a |
| Large Scale DNA Production Revenue Growth | -10.55% | n/a | n/a | n/a |
| Research and Development Services (Over-Time) Revenue | 311.24K | 421.58K | n/a | n/a |
| Research and Development Services (Over-Time) Revenue Growth | -26.17% | n/a | n/a | n/a |
| Supply Chain Revenue | 1.21M | 827.6K | n/a | n/a |
| Supply Chain Revenue Growth | +46.05% | n/a | n/a | n/a |
Revenue by Geography
| Period Ending | Sep 30, 2024 | Sep 30, 2023 | Sep 30, 2022 | Sep 30, 2021 | Sep 30, 2020 | Sep 30, 2019 | Sep 30, 2018 | Sep 30, 2017 | Sep 30, 2016 |
|---|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 2.27M | 12.22M | 17.54M | 147.89K | 266.7K | 600.37K | 1M | 1.06M | 876.79K |
| Americas Revenue Growth | -81.43% | -30.33% | +11762.93% | -44.55% | -55.58% | -40.23% | -4.80% | +20.34% | n/a |
| Asia And Other Revenue | 989.23K | 886.44K | 175.39K | 359.51K | n/a | n/a | n/a | n/a | n/a |
| Asia And Other Revenue Growth | +11.60% | +405.42% | -51.22% | n/a | n/a | n/a | n/a | n/a | n/a |
| Europe Revenue | 172.37K | 258.36K | 448.85K | n/a | n/a | n/a | n/a | n/a | n/a |
| Europe Revenue Growth | -33.28% | -42.44% | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 2.98M | 2.63M | 2.68M | 2.68M | 3M | 3.08M | 3.31M | 3.29M | 3.52M | 2.63M | 3.87M | 3.01M | 3.41M | 4.66M | 2.31M | 3.24M | 3.56M | 3.5M | 2.89M | 2.59M | 2.29M | 2.37M | 2.26M | 2.41M | 2.53M | 3.08M | 3.57M | 2.88M | 2M | 2.59M | 2.79M | 3.4M | 3.23M | 3.9M | 2.62M | 2.71M | 3.12M | 3.55M | 3.66M | 3.51M | 2.9M |
| Selling, General, and Administrative Revenue Growth | +13.30% | -1.91% | +0.21% | -10.71% | -2.73% | -6.84% | +0.57% | -6.54% | +34.18% | -32.22% | +28.51% | -11.69% | -26.80% | +101.63% | -28.63% | -8.93% | +1.62% | +21.13% | +11.63% | +13.28% | -3.70% | +5.04% | -6.14% | -4.81% | -17.96% | -13.70% | +23.92% | +44.35% | -23.00% | -7.07% | -18.00% | +5.34% | -17.19% | +48.71% | -3.11% | -13.24% | -12.21% | -2.83% | +4.26% | +20.93% | n/a |
| Research and Development Revenue | 849.36K | 1.02M | 831.71K | 913.03K | 726.87K | 935.82K | 938.91K | 836.12K | 988.74K | 971.3K | 912.88K | 863.02K | 1.07M | 1.08M | 1.11M | 1.03M | 874.05K | 748.37K | 1.24M | 814.6K | 703.02K | 564.43K | 886.67K | 719.67K | 651.38K | 709.56K | 716.69K | 625.01K | 669.81K | 740.07K | 524.75K | 603.1K | 635.89K | 518.63K | 832.23K | 1.08M | 729.08K | 471.93K | 673.64K | 310.09K | 373.38K |
| Research and Development Revenue Growth | -16.32% | +22.04% | -8.91% | +25.61% | -22.33% | -0.33% | +12.29% | -15.44% | +1.80% | +6.40% | +5.78% | -19.35% | -0.93% | -2.99% | +8.14% | +17.80% | +16.80% | -39.63% | +52.19% | +15.87% | +24.55% | -36.34% | +23.21% | +10.48% | -8.20% | -0.99% | +14.67% | -6.69% | -9.49% | +41.03% | -12.99% | -5.16% | +22.61% | -37.68% | -22.79% | +47.85% | +54.49% | -29.94% | +117.24% | -16.95% | n/a |